Ownership

Scott M. Robertson

Insider Reports History

Entity: Individual
Location: C/O Dice Therapeutics, Inc., 279 E. Grand Avenue, Suite 300, Lobby B, South San Francisco, CA
Signature: /s/ Lara Meisner, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Scott M. Robertson:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Bicara Therapeutics Inc.	Director	Stock Option (Right to Buy)	23.7K			Sep 12, 2024	Direct
DICE Therapeutics, Inc.	CFO & CBO	Common Stock	0		$46.50	Aug 9, 2023	Direct
DICE Therapeutics, Inc.	CFO & CBO	Restricted Stock Units	0			Aug 9, 2023	Direct
DICE Therapeutics, Inc.	CFO & CBO	Stock Option (right to buy)	0			Aug 9, 2023	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Scott M. Robertson

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
BCAX	Bicara Therapeutics Inc.	Sep 12, 2024	1	$0	4	Sep 16, 2024	Director
BCAX	Bicara Therapeutics Inc.	Sep 12, 2024	0	$0	3	Sep 12, 2024	Director
DICE	DICE Therapeutics, Inc.	Aug 9, 2023	12	$0	4	Aug 9, 2023	CFO & CBO
DICE	DICE Therapeutics, Inc.	May 3, 2023	1	-$685K	4	May 5, 2023	CFO & CBO
DICE	DICE Therapeutics, Inc.	Jan 27, 2023	2	$0	4	Jan 31, 2023	CFO & CBO
DICE	DICE Therapeutics, Inc.	Apr 14, 2022	1	$0	4	Apr 19, 2022	CFO & CBO
DICE	DICE Therapeutics, Inc.	Sep 14, 2021	14	$0	4	Sep 16, 2021	CFO & CBO
DICE	DICE Therapeutics, Inc.	Sep 14, 2021	0	$0	3	Sep 14, 2021	CFO & CBO